Education
About Us
Working with TipRanks
Follow Us
Seres Therapeutics (DE:1S9)
FRANKFURT:1S9
RESEARCH TOOLSreports
Seres Therapeutics (1S9) Ownership Overview
0.45% Insiders
11.15%
Mutual Funds
13.81% Other Institutional Investors
3.73% ETFs
70.86% Public Companies and
Individual Investors
The ownership structure of Seres Therapeutics (DE:1S9) stock is a mix of institutional, retail, and individual investors. Approximately 28.69% of the company’s stock is owned by Institutional Investors, 0.45% is owned by Insiders, and 70.86% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 23,117,045 | Institution | 13.26% | 15,881,410 | |
| 11,218,162 | Institution | 6.43% | 7,706,877 | |
| 5,693,722 | Institution | 3.27% | 3,911,587 | |
| 5,306,216 | Institution | 3.04% | 3,645,370 | |
| 2,045,871 | Institution | 1.17% | 1,405,513 | |
| 1,211,123 | Institution | 0.69% | 832,042 | |
| 749,537 | Institution | 0.43% | 514,932 | |
| 401,122 | Institution | 0.23% | 275,571 | |
| 330,500 | Institution | 0.19% | 227,054 | |
| 309,379 | Institution | 0.18% | 212,543 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,218,162 | Institution | 6.43% | 7,706,877 | |
| 5,306,216 | Institution | 3.04% | 3,645,370 | |
| 1,211,123 | Institution | 0.69% | 832,042 | |
| 401,122 | Institution | 0.23% | 275,571 | |
| 330,500 | Institution | 0.19% | 227,054 | |
| 289,219 | Institution | 0.17% | 198,693 | |
| 250,000 | Institution | 0.14% | 171,750 | |
| 159,614 | Institution | 0.09% | 109,655 | |
| 83,698 | Institution | 0.05% | 57,501 | |
| 69,975 | Institution | 0.04% | 48,073 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Seres Therapeutics (DE:1S9)?
According to the latest TipRanks data, approximately 13.81% of the company's stock is held by institutional investors, 0.45% is held by insiders, and 70.86% is held by retail investors.
What percentage of Seres Therapeutics (DE:1S9) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.81% of Seres Therapeutics (DE:1S9) stock is held by institutional investors.
What percentage of Seres Therapeutics (DE:1S9) stock is held by retail investors?
According to the latest TipRanks data, approximately 70.86% of Seres Therapeutics (DE:1S9) stock is held by retail investors.
Who owns the most shares of Seres Therapeutics (DE:1S9)?
Noubar Afeyan owns the most shares of Seres Therapeutics (DE:1S9).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.